37
Views
3
CrossRef citations to date
0
Altmetric
Review

Current treatment options for atrial flutter and results with cryocatheter ablation

&
Pages 191-202 | Published online: 10 Jan 2014

References

  • Lee KW, Yang Y, Scheinman MM. Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr. Probl. Cardiol. 30(3), 121–167 (2005).
  • Wellens HJ. Contemporary management of atrial flutter. Circulation 106(6), 649–652 (2002).
  • Halligan SC, Gersh BJ, Brown RD Jr et al. The natural history of lone atrial flutter. Ann. Intern. Med. 140(4), 265–268 (2004).
  • Biblo LA, Yuan Z, Quan KJ, Mackall JA, Rimm AA. Risk of stroke in patients with atrial flutter. Am. J. Cardiol. 87(3), 346–349, A9 (2001).
  • Corrado G, Sgalambro A, Mantero A et al. Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Societa Italiana di Ecografia Cardiovascolare) multicentre study. Eur. Heart J. 22(12), 1042–1051 (2001).
  • Sparks PB, Kalman JM. Is atrial flutter a risk factor for stroke? J. Am. Coll. Cardiol. 38(3), 785–788 (2001).
  • Ghali WA, Wasil BI, Brant R, Exner DV, Cornuz J. Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis. Am. J. Med. 118(2), 101–107 (2005).
  • Granada J, Uribe W, Chyou PH et al. Incidence and predictors of atrial flutter in the general population. J. Am. Coll. Cardiol. 36(7), 2242–2246 (2000).
  • Blomstrom-Lundqvist C, Scheinman MM, Aliot EM et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias– executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J. Am. Coll. Cardiol. 42(8), 1493–1531 (2003).
  • Pelletier E, Hernandez J, Clark M, Justason BFM. Medicare costs and resource use associated with atrial fibrillation patients. Heart Rhythm 1, S57, 175 (2004) (Abstract).
  • Weerasooriya R, Jais P, Le Heuzey JY et al. Cost analysis of catheter ablation for paroxysmal atrial fibrillation. Pacing Clin. Electrophysiol. 26(1 Pt. 2), 292–294 (2003).
  • Goldberg A, Menen M, Mickelsen S et al. Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources. J. Interv. Card. Electrophysiol. 8(1), 59–64 (2003).
  • Goodacre S, Irons R. ABC of clinical electrocardiography: atrial arrhythmias. BMJ 324(7337), 594–597 (2002).
  • Cosio FG, Martin-Penato A, Pastor A, Nunez A, Goicolea A. Atypical flutter: a review. Pacing Clin. Electrophysiol. 26(11), 2157–2169 (2003).
  • Cosio FG. Atrial flutter update. Card. Electrophysiol. Rev. 6(4), 356–364 (2002).
  • Jais P, Hocini M, Weerasoryia R et al. Atypical left atrial flutters. Card. Electrophysiol. Rev. 6(4), 371–377 (2002).
  • Ricard P, Imianitoff M, Yaici K et al. Atypical atrial flutters. Europace 4(3), 229–239 (2002).
  • van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, Tieleman RG, Crijns HJ. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am. J. Cardiol. 84(9A), 147R–151R (1999).
  • Waldo AL. Treatment of atrial flutter. Heart 84(2), 227–232 (2000).
  • Houghton T, Kaye GC. Implantable devices for treating tachyarrhythmias. BMJ 327(7410), 333–336 (2003).
  • Trohman RG, Parrillo JE. Direct current cardioversion: indications, techniques, and recent advances. Crit. Care Med. 28(Suppl. 10), N170–N173 (2000).
  • Purerfellner H. Recent developments in cardiovascular drug therapy: treatment of atrial arrhythmias with new class III drugs and beyond. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2(1), 79–91 (2004).
  • Sun JL, Guo JH, Zhang N, Zhang HC, Zhang P. Clinical comparison of ibutilide and propafenone for converting atrial flutter. Cardiovasc. Drugs Ther. 19(1), 57–64 (2005).
  • Reisinger J, Gatterer E, Lang W et al. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur. Heart J. 25(15), 1318–1324 (2004).
  • Khan MH. Oral class III antiarrhythmics: what is new? Curr. Opin. Cardiol. 19(1), 47–51 (2004).
  • Yamreudeewong W, DeBisschop M, Martin LG, Lower DL. Potentially significant drug interactions of class III antiarrhythmic drugs. Drug Saf. 26(6), 421–438 (2003).
  • Wooten JM, Earnest J, Reyes J. Review of common adverse effects of selected antiarrhythmic drugs. Crit. Care Nurs.Q. 22(4), 23–38; quiz 2 p following 100 (2000).
  • Nemec J, Shen WK. Antiarrhythmic drugs: new agents and evolving concepts. Expert Opin. Investig. Drugs 12(3), 435–453 (2003).
  • Tai CT, Chen SA. Mechanisms of antiarrhythmic drug action on termination of atrial flutter. Pacing Clin. Electrophysiol. 24(5), 824–834 (2001).
  • Foldesi C, Pandozi C, Peichl P et al. Atrial flutter: arrhythmia circuit and basis for radiofrequency catheter ablation. Ital. Heart J. 4(6), 395–403 (2003).
  • Yee R, Connolly S, Noorani H. Clinical review of radiofrequency catheter ablation for cardiac arrhythmias. Can. J. Cardiol. 19(11), 1273–1284 (2003).
  • Feld GK. Radiofrequency ablation of atrial flutter using large-tip electrode catheters. J. Cardiovasc. Electrophysiol. 15(Suppl. 10), S18–S23 (2004).
  • Feld G, Wharton M, Plumb V, Daoud E, Friehling T, Epstein L. Radiofrequency catheter ablation of type 1 atrial flutter using large-tip 8- or 10-mm electrode catheters and a high-output radiofrequency energy generator: results of a multicenter safety and efficacy study. J. Am. Coll. Cardiol. 43(8), 1466–1472 (2004).
  • Ventura R, Willems S, Weiss C et al. Large tip electrodes for successful elimination of atrial flutter resistant to conventional catheter ablation. J. Interv. Card. Electrophysiol. 8(2), 149–54 (2003).
  • Tsai CF, Tai CT, Yu WC et al. Is 8 mm more effective than 4-mm tip electrode catheter for ablation of typical atrial flutter? Circulation 100(7), 768–771 (1999).
  • Rodriguez LM, Nabar A, Timmermans C, Wellens HJ. Comparison of results of an 8-mm split-tip versus a 4-mm tip ablation catheter to perform radiofrequency ablation of type I atrial flutter. Am. J. Cardiol. 85(1), 109–112, A9 (2000).
  • Hsieh MH, Tai CT, Chiang CE et al. Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients. J. Interv. Card. Electrophysiol. 7(3), 225–231 (2002).
  • Lee DS, Dorian P, Downar E et al. Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation? Europace 3(3), 195–200 (2001).
  • Zhou L, Keane D, Reed G, Ruskin J. Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions. J. Cardiovasc. Electrophysiol. 10(4), 611–620 (1999).
  • Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin. Electrophysiol. 23(6), 1020–1028 (2000).
  • Collins N, Barlow M, Leitch JW et al. Cryoablation versus Radiofrequency Ablation in the treatment of Atrial Flutter Trial (CRAAFT). Heart Rhythm 2005 Scientific Sessions. New Orleans, LA, USA, May 4–7, (2005).
  • Daubert JP, Hoyt RH, John R et al. Performance of a new cardiac cryoablation system in the treatment of cavotricuspid valve isthmus-dependent atrial flutter. Pacing Clin. Electrophysiol. 28 (Suppl. 1), S142–S145 (2005).
  • Friedman PL. Catheter cryoablation of cardiac arrhythmias. Curr. Opin. Cardiol. 20(1), 48–54 (2005).
  • Khairy P, Chauvet P, Lehmann J et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 107(15), 2045–2050 (2003).
  • Kuniss M, Kurzidim K, Greiss H, Zaltsberg S, Sperzel J, Pitschner HF. Persistency of bi-directional conduction block in the cavotricuspid isthmus one month after cryocatheter ablation (8mm-tip) of common atrial flutter. Heart Rhythm 2005 Scientific Sessions, New Orleans, LA, USA, May 4–7, (2005).
  • Lowe MD, Meara M, Mason J, Grace AA, Murgatroyd FD. Catheter cryoablation of supraventricular arrhythmias: a painless alternative to radiofrequency energy. Pacing Clin. Electrophysiol. 26(1 Pt. 2), 500–503 (2003).
  • Manusama R, Timmermans C, Limon F, Philippens S, Crijns HJGM, Rodriguez L-M. Catheter-based cryoablation permanently cures patients with common atrial flutter. Circulation 109(13), 1636–1639 (2004).
  • Manusama R, Timmermans C, Philippens S, Crijns HJ, Ayers GM, Rodriguez LM. Single cryothermia applications of less than five minutes produce permanent cavotricuspid isthmus block in humans. Heart Rhythm 1(5), 594–599 (2004).
  • Montenero A, Bruno N, Antonelli A et al. Long-term efficacy of cryo-catheter ablation for the treatment of atrial flutter – results from a repeat electrophysiologic study. J. Am. Coll. Cardiol. 45, 573–580 (2005).
  • Montenero AS, Bruno N, Zumbo F et al. Cryothermal ablation treatment of atrial flutter– experience with a new 9 French 8 mm tip catheter. J. Interv. Card. Electrophysiol. 12(1), 45–54 (2005).
  • Montenero AS, Bruno N, Antonelli A et al. Comparison between a 7 French 6 mm tip cryothermal catheter and a 9 French 8 mm tip cryothermal catheter for cryoablation treatment of common atrial flutter. J. Interv. Card. Electrophysiol. 13(1), 59–69 (2005).
  • Rodriguez LM, Geller JC, Tse HF et al. Acute results of transvenous cryoablation of supraventricular tachycardia (atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome, atrioventricular nodal reentry tachycardia). J. Cardiovasc. Electrophysiol. 13(11), 1082–1089 (2002).
  • Rodriguez LM, Timmermans C. Transvenous cryoablation of cardiac arrhythmias. Technol Cancer Res Treat. 3(5), 515–524 (2004).
  • Skanes AC, Yee R, Krahn AD, Klein GJ. Cryoablation of atrial arrhythmias. Card. Electrophysiol. Rev. 6(4), 383–388 (2002).
  • Skanes AC, Klein G, Krahn A, Yee R. Cryoablation: potentials and pitfalls. J. Cardiovasc. Electrophysiol. 15(Suppl. 10), S28–S34 (2004).
  • Timmermans C, Ayers GM, Crijns HJ, Rodriguez LM. Randomized study comparing radiofrequency ablation with cryoablation for the treatment of atrial flutter with emphasis on pain perception. Circulation 107(9), 1250–1252 (2003).
  • van Oeveren W, Crijns HJ, Korteling BJ et al. Blood damage, platelet and clotting activation during application of radiofrequency or cryoablation catheters: a comparative in vitro study. J Med Eng Technol. 23(1), 20–25 (1999).
  • Dubuc M, Talajic M, Roy D, Thibault B, Leung TK, Friedman PL. Feasibility of cardiac cryoablation using a transvenous steerable electrode catheter. J. Interv. Card. Electrophysiol. 2(3), 285–292 (1998).
  • Timmermans C, Rodriguez LM, van Suylen RJ et al. Catheter-based cryoablation produces permanent bidirectional cavotricuspid isthmus conduction block in dogs. J. Interv. Card. Electrophysiol. 7(2), 149–155 (2002).
  • Santini M, Pignalberi C, Ricci R, Calo L. Hybrid therapy of atrial fibrillation. Ital. Heart J. 3(10), 571–578 (2002).
  • Kocheril AG, Calkins H, Sharma AD, Cher D, Stubbs HA, Block JE. Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation. J. Interv. Card. Electrophysiol. 12(3), 189–197 (2005).
  • Calo L, Lamberti F, Loricchio ML et al. Atrial flutter and atrial fibrillation: which relationship? New insights into the electrophysiological mechanisms and catheter ablation treatment. Ital. Heart J. 6(5), 368–373 (2005).
  • Okishige K, Aonuma K, Yamauchi Y et al. Clinical study of the efficacy of a cooled-tip catheter ablation system for common atrial flutter. Circ. J. 68(1), 73–76 (2004).
  • Scavee C, Jais P, Hsu LF et al. Prospective randomised comparison of irrigated-tip and large-tip catheter ablation of cavotricuspid isthmus-dependent atrial flutter. Eur. Heart J. 25(11), 963–969 (2004).
  • Ohkubo T, Okishige K, Goseki Y, Matsubara T, Hiejima K, Ibukiyama C. Experimental study of catheter ablation using ultrasound energy in canine and porcine hearts. Jpn. Heart J. 39(3), 399–409 (1998).
  • Lee LA, Simon C, Bove EL et al. High intensity focused ultrasound effect on cardiac tissues: potential for clinical application. Echocardiography 17(6 Pt. 1), 563–566 (2000).
  • Zimmer JE, Hynynen K, He DS, Marcus F. The feasibility of using ultrasound for cardiac ablation. IEEE Trans. Biomed. Eng. 42(9), 891–897 (1995).
  • Iwasa A, Storey J, Yao B, Liem LB, Feld GK. Efficacy of a microwave antenna for ablation of the tricuspid valve–inferior vena cava isthmus in dogs as a treatment for type 1 atrial flutter. J. Interv. Card. Electrophysiol. 10(3), 191–198 (2004).
  • Rappaport C. Cardiac tissue ablation with catheter-based microwave heating. Int. J. Hyperthermia 20(7), 769–780 (2004).
  • Karolyi L, Spitzer SG, Geller L et al. Isthmus ablation with a novel microwave catheter in dogs. IEEE Eng. Med. Biol. Mag. 24(1), 45–50 (2005).
  • Keane D, Ruskin JN. Linear atrial ablation with a diode laser and fiberoptic catheter. Circulation 100(14), E59–E60 (1999).
  • Keane D. New catheter ablation techniques for the treatment of cardiac arrhythmias. Card. Electrophysiol. Rev. 6(4), 341–348 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.